Effects of Oestradiol and Tamoxifen on Angiogenic Factors in Breast Cancer
Author Information
Author(s): Garvin S, Nilsson U W, Dabrosin C
Primary Institution: University Hospital, Linköping, Sweden
Hypothesis
How do oestradiol and tamoxifen affect the balance of angiogenic factors in breast cancer?
Conclusion
Tamoxifen and oestradiol have opposing effects on angiogenic factors in breast cancer, influencing tumor growth and vasculature.
Supporting Evidence
- Oestradiol decreased secreted sVEGFR-1 and increased secreted VEGF in MCF-7 cells.
- Tamoxifen opposed the effects of oestradiol on angiogenic factors.
- MCF-7 tumors from oestradiol+tamoxifen-treated mice exhibited decreased tumor vasculature.
Takeaway
This study found that oestradiol increases a substance that helps tumors grow, while tamoxifen works against it, showing how these hormones affect breast cancer.
Methodology
The study used MCF-7 breast cancer cells and human umbilical vein endothelial cells (HUVEC) to assess the effects of oestradiol and tamoxifen on angiogenic factors in vitro and in a mouse model in vivo.
Limitations
The study did not include an untreated control group or a tamoxifen-alone group in the experimental design.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website